Abstract
Elevated whole blood serotonin (WB5-HT) is a well-replicated biomarker in autism spectrum disorder (ASD). Decreased platelet serotonin receptor 5-HT2A binding has been reported in ASD. WB5-HT levels and platelet 5-HT2A specific binding were obtained from 110 individuals with ASD and 18 controls. Individuals with ASD had significantly higher WB5-HT levels than controls. There was no difference in the platelet 5-HT2A specific binding between groups. Multiple regression analyses revealed that platelet 5-HT2A binding significantly predicted WB5-HT in the control sample but not in the ASD sample. These results indicate that the relationship between WB5-HT and platelet 5-HT2A binding differs depending on ASD diagnosis, suggesting differences in platelet 5-HT system regulation in ASD.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2417-2425 |
| Number of pages | 9 |
| Journal | Journal of Autism and Developmental Disorders |
| Volume | 49 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2019 |
Bibliographical note
Publisher Copyright:© Springer Science+Business Media, LLC, part of Springer Nature 2019.
Keywords
- Autism spectrum disorder
- Biomarker
- Hyperserotonemia
- Receptor
- Serotonin
Fingerprint
Dive into the research topics of 'Whole Blood Serotonin Levels and Platelet 5-HT2A Binding in Autism Spectrum Disorder'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS